Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy

NCT05861362 is registered in ClinicalTrials.gov with MVZ Leopoldina GmbH as lead sponsor.

NCT NCT05861362
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05861362 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Metabolic Effects of a 5:2 Fasting Intervention in Women With Breast Cancer During Radiotherapy
Lead sponsor
MVZ Leopoldina GmbH
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2022
Completion date
November 17, 2022
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer